BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30407103)

  • 1. Acute myeloid leukemia in the elderly: what constitutes treatment value?
    Nabhan C; Kamat S; Karl Kish J
    Leuk Lymphoma; 2019 May; 60(5):1164-1170. PubMed ID: 30407103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine before Low-Dose Cytarabine-Based Chemotherapy Combined with Human Leukocyte Antigen-Mismatched Stem Cell Microtransplantation Improved Outcomes in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Zhu Y; Zhao H; Zhang X; Wu Y; Xie Y; Li Y; Lian Y; Huang J; Li J; Chen Y; Qian S
    Biol Blood Marrow Transplant; 2017 May; 23(5):830-835. PubMed ID: 28189902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute myeloid leukemia of the elderly: recent progresses in therapy].
    Yamauchi T
    Rinsho Ketsueki; 2018; 59(6):735-740. PubMed ID: 29973453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
    DiNardo CD; Pratz KW; Letai A; Jonas BA; Wei AH; Thirman M; Arellano M; Frattini MG; Kantarjian H; Popovic R; Chyla B; Xu T; Dunbar M; Agarwal SK; Humerickhouse R; Mabry M; Potluri J; Konopleva M; Pollyea DA
    Lancet Oncol; 2018 Feb; 19(2):216-228. PubMed ID: 29339097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial.
    Kadia TM; Cortes J; Ravandi F; Jabbour E; Konopleva M; Benton CB; Burger J; Sasaki K; Borthakur G; DiNardo CD; Pemmaraju N; Daver N; Ferrajoli A; Wang X; Patel K; Jorgensen JL; Wang S; O'Brien S; Pierce S; Tuttle C; Estrov Z; Verstovsek S; Garcia-Manero G; Kantarjian H
    Lancet Haematol; 2018 Sep; 5(9):e411-e421. PubMed ID: 30115541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease may be an early prognostic indicator for newly diagnosed acute myeloid leukemia patients induced by decitabine-based chemotherapy.
    Tan Y; Fu Y; Liu C; Sun J; Liu S; Lin H; Liu Q; Yang Y; Li Y; Su L; Gao S
    Hematology; 2019 Dec; 24(1):552-558. PubMed ID: 31315553
    [No Abstract]   [Full Text] [Related]  

  • 7. DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy.
    Grishina O; Schmoor C; Döhner K; Hackanson B; Lubrich B; May AM; Cieslik C; Müller MJ; Lübbert M
    BMC Cancer; 2015 May; 15():430. PubMed ID: 26008690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
    Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Efficacy of Decitabine-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia].
    Li GH; Chen RA; Ji YR; Qin WW; Chen Y; Wang WQ; Liu C; Zhou NC; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):743-749. PubMed ID: 29950214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia.
    Choi EJ; Lee JH; Park HS; Lee JH; Seol M; Lee YS; Kang YA; Jeon M; Woo JM; Lee KH
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):290-299.e3. PubMed ID: 30879987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review.
    Bell JA; Galaznik A; Huelin R; Stokes M; Guo Y; Fram RJ; Faller DV
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):e303-e314. PubMed ID: 29802009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
    Li X; Xu S; Tan Y; Chen J
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia in the elderly: therapeutic options and choice.
    Webster JA; Pratz KW
    Leuk Lymphoma; 2018 Feb; 59(2):274-287. PubMed ID: 28573892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The artful management of older patients with acute myeloid leukemia.
    Yang J; Schiffer CA
    Expert Rev Hematol; 2016 May; 9(5):425-32. PubMed ID: 26878693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting initial treatment of acute myeloid leukaemia in older adults.
    Podoltsev NA; Stahl M; Zeidan AM; Gore SD
    Blood Rev; 2017 Mar; 31(2):43-62. PubMed ID: 27745715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Elderly Patients With Acute Myeloid Leukemia.
    Thomas X; Le Jeune C
    Curr Treat Options Oncol; 2017 Jan; 18(1):2. PubMed ID: 28144802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
    Shahzad M; Chaudhary SG; Tariq E; Mushtaq AH; Anwar I; Ahmed N; Bansal R; Lutfi F; Balusu R; Abdelhakim H; Yacoub A; Hematti P; Singh AK; McGuirk JP; Mushtaq MU
    Leuk Lymphoma; 2023 Feb; 64(2):273-282. PubMed ID: 36282773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Spagnoli A; Voso MT; Fianchi L; Papayannidis C; Gaidano GL; Breccia M; Musto P; De Bellis E; Del Principe MI; Lunghi M; Lessi F; Martinelli G; Venditti A
    Ann Hematol; 2018 Oct; 97(10):1767-1774. PubMed ID: 29947973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study.
    Li X; Dong Y; Li Y; Ren R; Wu W; Zhu H; Zhang Y; Hu J; Li J
    BMC Cancer; 2019 Aug; 19(1):819. PubMed ID: 31429724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blind men and the AML elephant: can we feel the progress?
    Tauro S
    Blood Cancer J; 2016 May; 6(5):e424. PubMed ID: 27176800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.